In humans, SDHA mutations cause neurodegeneration, muscle weakness and tumor formation (Al-Rasheed and Tarjan, 2018; Hadrava Vanova et al., 2020; Patel et al., 2012; Rutter et al., 2010). Here, SDHA is linked to neoplasm.